SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001558370-19-011631
Filing Date
2019-12-20
Accepted
2019-12-19 20:23:33
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 f424b5.htm 424B5 612004
2 GRAPHIC f424b5g001.jpg GRAPHIC 18292
3 GRAPHIC f424b5g002.jpg GRAPHIC 139461
4 GRAPHIC f424b5g003.jpg GRAPHIC 75472
5 GRAPHIC f424b5g004.jpg GRAPHIC 141422
  Complete submission text file 0001558370-19-011631.txt   1129303
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-235372 | Film No.: 191297479
SIC: 2834 Pharmaceutical Preparations